Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Correction

Published on 06 Mar 2025

Corrigendum: Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tianyi Huang
Jing Chen
Lu Zhang
Rui Wang
Yiheng Liu
Cuihua Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1578891

340 views

Original Research

Published on 04 Mar 2025

A CT-based radiomics nomogram for the preoperative prediction of perineural invasion in pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yan Deng
Haopeng Yu
Xiuping Duan
Li Liu
Zixing Huang
Bin Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1525835

409 views

Original Research

Published on 04 Mar 2025

Prognostic value of disulfidptosis-associated genes in gastric cancer: a comprehensive analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jin Tang
Jing Yang
Long-Kuan Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1512394

862 views

Original Research

Published on 26 Feb 2025

Significance of mouse xenograft tumor model using patient-derived cancer organoids for clinical drug development

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hisataka Ogawa
Keiichi Yoshida
Shinichiro Hasegawa
Hiroshi Wada
Masayoshi Yasui
Hideaki Tahara

Frontiers in Oncology

doi 10.3389/fonc.2025.1485886

674 views

Original Research

Published on 25 Feb 2025

Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Junfeng Bu
Zihan Li
Die Hu
Ling Lan
Jiwei Huang
Xin Wang
Qiu Li
Jin Zhou
Yong Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1554711

544 views

Original Research

Published on 24 Feb 2025

Efficacy and prognostic impact of preoperative risk factors for salvage liver transplantation and repeat hepatectomy in patients with early-stage recurrent hepatocellular carcinoma: a propensity score-matched analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Linfeng Yang
Yang Huang
Dawei Deng
Junning Liu
Liangliang Xu
Pengsheng Yi

Frontiers in Oncology

doi 10.3389/fonc.2025.1547054

565 views

Original Research

Published on 20 Feb 2025

A novel nomogram based on complement C3 to predict the overall survival of early-stage hepatocellular carcinoma patients with microvascular invasion-positive undergoing curative resection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Guoyi Xia
Zeyan Yu
Shaolong Lu
Xiaobo Wang
Yuanquan Zhao
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1559083

578 views

Original Research

Published on 19 Feb 2025

Clinical value of the nomogram model based on endoscopic ultrasonography radiomics and clinical indicators in identifying benign and malignant lesions of the pancreas

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiaofei Fan
Jia Huang
Xiaohan Cai
Ayixie Maihemuti
Shu Li
Weili Fang
Bangmao Wang
Wentian Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1504593

461 views

Original Research

Published on 19 Feb 2025

Differentiating pancreatic ductal adenocarcinoma and autoimmune pancreatitis using a machine learning model based on ultrasound clinical features

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lihua Zhang
Xiang Chen
Zhikui Chen
Weiji Chen
Jianmei Zheng
Minling Zhuo
Xing Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1505376

636 views

Systematic Review

Published on 14 Feb 2025

Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer: a systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xutao Jiang
Yu Zhu
Jianwei Li
Wei Li
Weizong Zheng
Caiming Xu
Guixin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1510342

515 views

Review

Published on 13 Feb 2025

Research trends and hotspots evolution of artificial intelligence for cholangiocarcinoma over the past 10 years: a bibliometric analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ke-xie Wang
Yu-ting Li
Sun-hu Yang
Feng Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1454411

1,143 views

Original Research

Published on 13 Feb 2025

Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Baixue Liu
Youguang Ao
Chunhui Liu
Feiyun Bai
Zhi Zhou
Juan Huang
Qi Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1485421

1,055 views

Systematic Review

Published on 12 Feb 2025

Drug-eluting beads transarterial chemoembolization vs conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma in adult patients: a systematic review and update meta-analysis of observational studies

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tatiana Chernyshenko
Roman Polkin
Ekaterina Dvoinikova
Valeriy Shepelev
Roman Goncharuk

Frontiers in Oncology

doi 10.3389/fonc.2024.1526268

555 views

Systematic Review

Published on 12 Feb 2025

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lingling Zhao
Cheng Xu
Jiewen Deng
Yang Ni

Frontiers in Oncology

doi 10.3389/fonc.2025.1513394

873 views

Systematic Review

Published on 06 Feb 2025

Research progress of MRI-based radiomics in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiao-Yun Xie
Rong Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1420599

1,506 views

Original Research

Published on 06 Feb 2025

Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Taylor Davis
Katherine T. Decker
Dana Hosseini
Gayle Jameson
Erkut Borazanci

Frontiers in Oncology

doi 10.3389/fonc.2025.1495500

632 views